Recent progress in mapping the emerging landscape of the small-cell lung cancer genome

Small-cell lung cancer (SCLC) remains the deadliest of all the lung cancer types. Its high mortality is largely attributed to the invariable development of resistance to standard chemo/radiotherapies, which have remained unchanged for the past 30 years, underscoring the need for new therapeutic appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kee-Beom, Dunn, Colin T., Park, Kwon-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906379/
https://www.ncbi.nlm.nih.gov/pubmed/31827074
http://dx.doi.org/10.1038/s12276-019-0349-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906379/
https://www.ncbi.nlm.nih.gov/pubmed/31827074
http://dx.doi.org/10.1038/s12276-019-0349-5

Ejemplares similares